2021
DOI: 10.3390/vaccines9091018
|View full text |Cite
|
Sign up to set email alerts
|

Cellular Immunotherapy and the Lung

Abstract: The new era of cellular immunotherapies has provided state-of-the-art and efficient strategies for the prevention and treatment of cancer and infectious diseases. Cellular immunotherapies are at the forefront of innovative medical care, including adoptive T cell therapies, cancer vaccines, NK cell therapies, and immune checkpoint inhibitors. The focus of this review is on cellular immunotherapies and their application in the lung, as respiratory diseases remain one of the main causes of death worldwide. The on… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 8 publications
(2 citation statements)
references
References 146 publications
0
2
0
Order By: Relevance
“…Further optimisation of lung dose may be possible through the use of more sophisticated devices such as those that make use of breath actuation or tailored/smaller droplet sizes [48][49][50][51]. This may be a critical consideration in the administration of novel, high-value therapeutics, such as advanced therapeutic medicinal products (ATMPs) or those with associated adverse side effects when suboptimal doses are delivered [52][53][54][55][56].…”
Section: Discussionmentioning
confidence: 99%
“…Further optimisation of lung dose may be possible through the use of more sophisticated devices such as those that make use of breath actuation or tailored/smaller droplet sizes [48][49][50][51]. This may be a critical consideration in the administration of novel, high-value therapeutics, such as advanced therapeutic medicinal products (ATMPs) or those with associated adverse side effects when suboptimal doses are delivered [52][53][54][55][56].…”
Section: Discussionmentioning
confidence: 99%
“…[1] As a result, TCs-related immunotherapy has shown the most potential. [2] While this immunotherapy is effective in DOI: 10.1002/adhm.202301536 the treatment of cancer, [3] autoimmune diseases, [4] and chronic inflammation, [5] the clinical effect is not always satisfactory. One important reason is the over-activation or insufficient activation of TCs due to the excessive or lack of mature DCs.…”
Section: Introductionmentioning
confidence: 99%